Edition:
India

People: Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

51.35USD
22 May 2019
Change (% chg)

$-0.01 (-0.02%)
Prev Close
$51.36
Open
$51.00
Day's High
$51.96
Day's Low
$50.46
Volume
145,411
Avg. Vol
172,889
52-wk High
$99.77
52-wk Low
$41.63

Clark, Ian 

Mr. Ian T. Clark is Independent Director of the Company. Mr. Clark has more than 30 years of experience in the biotechnology industry. Mr. Clark currently serves as an operating partner at Clarus Ventures, a venture capital firm. Prior to that, he was chief executive officer and head of North American Commercial Operations of Genentech (now a member of the Roche Group), a position he held since 2010. Mr. Clark also led the Genentech executive committee and was a member of the Genentech board of directors. Mr. Clark joined Genentech in 2003 as senior vice president and general manager, bio-oncology. In 2005, he was named senior vice president, commercial operations and became a member of the executive committee, and in 2006, he was named executive vice president, commercial operations. In 2009, he was named head of global product strategy and chief marketing officer of Roche. Prior to joining Genentech, Mr. Clark served as general manager of Novartis Canada, overseeing all of the company’s Canadian operations. Before assuming his post in Canada, Mr. Clark received a B.S. degree in biological sciences and an honorary doctorate from Southampton University in the United Kingdom

Basic Compensation

Total Annual Compensation, USD 48,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 266,833
Fiscal Year Total, USD 315,583

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Schenkein

5,972,360

Jacqualyn Fouse

672,036

Andrew Hirsch

2,320,060

Darrin Miles

--

Scott Biller

2,301,880

Christopher Bowden

2,330,810
As Of  31 Dec 2017